Global AI Drug Development Platform Supply, Demand and Key Producers, 2023-2029

Global AI Drug Development Platform Supply, Demand and Key Producers, 2023-2029

The global AI Drug Development Platform market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global AI Drug Development Platform demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for AI Drug Development Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Development Platform that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global AI Drug Development Platform total market, 2018-2029, (USD Million)

Global AI Drug Development Platform total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: AI Drug Development Platform total market, key domestic companies and share, (USD Million)

Global AI Drug Development Platform revenue by player and market share 2018-2023, (USD Million)

Global AI Drug Development Platform total market by Type, CAGR, 2018-2029, (USD Million)

Global AI Drug Development Platform total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global AI Drug Development Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI Drug Development Platform market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global AI Drug Development Platform Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global AI Drug Development Platform Market, Segmentation by Type
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode

Global AI Drug Development Platform Market, Segmentation by Application
SMEs
Large Enterprises

Companies Profiled:
Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba

Key Questions Answered

1. How big is the global AI Drug Development Platform market?

2. What is the demand of the global AI Drug Development Platform market?

3. What is the year over year growth of the global AI Drug Development Platform market?

4. What is the total value of the global AI Drug Development Platform market?

5. Who are the major players in the global AI Drug Development Platform market?

6. What are the growth factors driving the market demand?